Comparison of thrombotic events and mortality in patients with community-acquired pneumonia and COVID-19: a multicentre observational study.

Roberto CangemiCamilla CalvieriMarco FalconeFrancesco CipolloneGiancarlo CeccarelliPasquale PignatelliDamiano D'ArdesMatteo PirroFrancesco AlessandriMiriam LichtnerGabriella D'EttorreAlessandra OlivaRaissa AronicaMonica RoccoMario VendittiGiulio Francesco RomitiGiusy TiseoGloria TalianiFrancesco MenichettiFrancesco PuglieseClaudio Maria MastroianniFrancesco Violi

Published in: Thrombosis and haemostasis (2021)

Compared with CAP, COVID-19 is characterized by a higher burden of thrombotic events, different thrombosis typology and higher risk of thrombosis-related in-hospital mortality.

Keyphrases

coronavirus disease
community acquired pneumonia
sars cov
pulmonary embolism
risk factors
clinical trial
cardiovascular events
respiratory syndrome coronavirus
randomized controlled trial
coronary artery disease
double blind